Evidence map›Paper›PMID 41766014›Full record

ArticleScientific reports2026

Ag

Jinghan Wang, Peng Hou, Qingwei Yao, Shuang Fu, Liyuan Chao, Huimin Sui, Lu Han, Jiafeng Wang, Guowei Wang, Hongguang Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jinghan WangTrade Union of Qiqihar Medical University, Qiqihar, 161006, PR China.
Peng HouCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, PR China.
Qingwei YaoCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, PR China.
Shuang FuCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, PR China.
Liyuan ChaoCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, PR China.
Huimin SuiCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, PR China.
Lu HanCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, PR China.
Jiafeng WangCollege of Pathology, Qiqihar Medical University, Qiqihar, 161006, PR China.
Guowei WangCollege of Pathology, Qiqihar Medical University, Qiqihar, 161006, PR China.
Hongguang ZhangCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, PR China. zhanghg@qmu.edu.cn.

Funding

Construction Project of Dominant Characteristic Disciplines of Qiqihar Medical University QYZDXK-008Key Cultivation Project of Qiqihar Medical Science Academy 2021-ZDPY-007
6 · The paper itself

Abstract

Surface-enhanced Raman scattering (SERS) technology has emerged as a powerful analytical tool for trace-level environmental pollutant detection, with its performance critically dependent on the physicochemical properties of substrate materials. While noble metal substrates (e.g., Au/Ag) demonstrate superior SERS enhancement through surface plasmon resonance (SPR), their practical deployment is hampered by inherent limitations including high material costs and susceptibility to oxidation-induced degradation. Herein, we report the rational design of Ag

Indexed as

Ag2O/TiO2Crystal violetPhotoinduced charge transferSERSTrace analysis

Identifiers

PMID41766014
PMCPMC13057315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.